Long considered dull patches to hide under clothes, eczema discreetly changes its face. This chronic inflammatory disease, marked by intense itching and dry, cracking skin, affects millions of people without always being seen. And yet, a new era is dawning, between medical breakthroughs, more desirable care and the speaking out of public figures who no longer accept to suffer in silence.
In France, around 15% of children and 4% of adults live with atopic dermatitis, while in the United States the number of people affected is estimated at 31 million. These patients are seeing the emergence of targeted biotherapies, new anti-JAK tablets, non-steroidal creams and even makeup designed for eczematous skin. But the question remains: to what extent do these innovations actually change the daily lives of the people concerned?
Understanding eczema today as a true inflammatory disease
Far from being a simple dryness, eczema corresponds to a weakened skin barrier which allows water to escape and irritants to enter, triggering a disproportionate immune response. This vicious circle feeds redness, itching and inflammation, sometimes to the point of disrupting sleep or professional life. For moderate to severe forms, specialists now speak of a systemic illness with a real impact on mental health.
As dermatologist Payvand Kamrani summarizes, . She adds that. This change in outlook paves the way for targeted treatments that mark the next era of eczema.
New treatments for eczema: beyond corticosteroids
For a long time, dermatologists relied mainly on corticosteroid creams and emollients. , explains dermatologist Deborah Longwill in an interview with NewBeauty. Since the 2000s, non-steroidal creams, biotherapies using monoclonal antibodies, JAK or PDE4 inhibitors have enriched the arsenal, particularly for the most severe forms.
Biotherapies such as dupilumab opened the way in 2017, quickly joined by anti-JAK tablets which finely target certain inflammatory pathways. As for local treatments, molecules like roflumilast offer options without corticosteroids, in foam for the scalp or in cream for the skin. Gymnast Simone Biles tells Healthline, before receiving a diagnosis and appropriate prescription treatment.
Beauty, destigmatization and research: the next era of eczema
This new era is also playing out in the beauty departments, where barrier care and “eczema friendly” labels are multiplying. The National Eczema Association issues a very strict Seal of Acceptance, now also granted to certain foundations and primers for reactive skin, in a sensitive skin market which could reach 81 billion dollars (around 75 billion euros) in 2030., recalls Kristin Belleson, who emphasizes that only an independent evaluation guarantees a real level of safety, far from label promises. Dermatologist Payvand Kamrani summarizes the right approach: .
Scientifically, teams supported by Inserm have shown that resident memory T lymphocytes and inhibitory checkpoint receptors control allergic memory in the skin, opening the way to treatments capable of reducing relapses. For dermatologist Angela Lamb, . For her part, Simone Biles recalls that, emphasizing the place of mental well-being and speech in regaining control.
What are the new treatments for eczema?
Biotherapies, anti-JAK and non-steroidal creams complement traditional corticosteroids for moderate to severe forms.
Can “eczema friendly” cosmetics replace medical treatment?
No, they support the skin barrier and hydration between breakouts, but do not address underlying inflammation.
What does the NEA Seal of Acceptance do?
This label guarantees that the product has been evaluated by experts, avoids the main known triggers and is suitable for eczematous skin.
